References
E. S. Akarachkova, “Use of ‘Magne-B6’ in wide therapeutic practice,” Trudnyi Patsient, 5, 48–54 (2007).
E. S. Akarachkova, “Clinical signs of maladaptation and magnesium deficiency in women aged over 40 years,” in: Healthy Woman after 40 Years: Proc. Sci. Appl. Conf. of Gynecologists, Moscow Medical Academy, May 29–30, 2008 [in Russian], Moscow (2008).
E. S. Akarachkova, Asthenia: Characteristics and Contemporary Treatment Agents [in Russian], Novaya Apteka (2008).
E. S. Akarachkova, M. Yu. Drobizhev, O. V. Vorobiova, and E. A. Makukh, “Nonspecific pain and depression in neurology,” Zh. Nevrol. Psikhiat., No. 12, 4–10 (2008).
E. S. Akarachkova, M. Yu. Drobizhev, and E. A. Makukh, “Asthenia and depression in neurological practice,” Lech. Nerv. Bolezn., 3, No. 25, 35–41 (2008).
E. S. Akarachkova, “Calcium channel blockers in neurological practice,” Vrach, No. 9, 35–39 (2009).
O. V. Vorobiova and E. S. Akarachkova, “Magne B6: experience of five years of clinical use in neurological and therapeutic practice,” Farmateka, 20, 734–80 (2008).
O. A. Gromova, Magnesium and Pyridoxine: A Knowledge Base [in Russian], Moscow (2006).
I. V. Damulin, “Moderate cognitive disorders: some pathogenetic, clinical, and therapeutic aspects,” Consilium Medicum, No. 2, 19–24 (2008).
V. A. Doskin, N. A. Lavrentiev, M. P. Miroshnikov, and V. B. Sharai, 1 MMI (1973).
R. Murray, D. Grenner, and V. Rodwell, Human Biochemistry [Russian translation], Mir, Moscow (1993), Vol. 2.
Pathophysiology. A Course of Lectures: A Textbook [in Russian], Moscow (1995).
S. B. Shvarkov and E. S. Akarachkova, “Correction of energy and electrolyte balance with magnesium formulations and pyridoxine in neurological diseases,” Med. Tekhnol., 31 (2007).
S. Ax, V. H. Gregg, and D. Jones, “Chronic fatigue syndrome: sufferers’ evaluation of medical support,” J. Roy. Soc. Med., 90, 250–254 (1997).
H. Aydin, O. Deyneli, D. Yavuz, et al., “Short-term oral magnesium supplementation suppresses bone turnover in postmenopausal osteoporotic women,” Biol. Trace Elem. Res., 133, No. 2, 136–143 (2010).
M. Barbagallo, M. Belvedere, and L. J. Dominguez, “Magnesium homeostasis and aging,” Magnes. Res., 22, No. 4, 235–246 (2009).
R. Day, W. Liauw, et al., “A double-blind, placebo-controlled study of the short-term effects of a spring water supplemented with magnesium bicarbonate on acid/base balance, bone metabolism and cardiovascular risk factors in postmenopausal women,” BMC Res. Not., 3, 180 (2010).
G. A. Eby and K. L. Eby, “Magnesium for treatment-resistant depression: a review and hypothesis,” Med. Hypothes, 74, No. 4, 649–660 (2010).
K. Fukuda, S. E. Straus, I. Hickie, et al., “The chronic fatigue syndrome: a comprehensive approach to its definition and study,” Ann. Int. Med., 121, 953–959 (1994).
L. S. Hadjistavri, P. A. Sarafidis, P. I. Georgianos, et al., “Beneficial effects of oral magnesium supplementation on insulin sensitivity and serum lipid profile,” Med. Sci. Monit., 16, No. 6, 307–312 (2010).
F. N. Jacko, S. Overland, R. Stewart, et al., “Association between magnesium intake and depression and anxiety in community-dwelling adults: the Hordaland Health Study,” New Zealand J. Psychiat., 43, No. 1, 45–52 (2009).
R. Jorgensen, “Chronic fatigue: an evolutionary concept analysis,” J. Adv. Nurs., 63, No. 2, 199–207 (2008).
R. J. Lane, B. A. Soteriou, H. Zhang, and L. C. Archard, “Enterovirus related metabolic myopathy: a postviral fatigue syndrome,” J. Neurol. Neurosurg. Psychiat., 74, No. 10, 1382–1386 (2003).
M. Nechifor, “Interactions between magnesium and psychotropic drugs,” Magnes. Res., 21, No. 2, 97–100 (2008).
M. Nechifor, “Magnesium in major depression,” Magnes. Res., 22, No. 3, 163–166 (2009).
R. Nisenbaum, J. Jones, E. Unger, et al., “A population-based study of the clinical course of chronic fatigue syndrome,” Health Qualit. Life Outcomes, No. 1, 49 (2003).
R. Pokan, P. Hofmann, S. P. von Duvillard, et al., “Oral magnesium therapy, exercise heart rate, exercise tolerance, and myocardial function in coronary artery disease patients,” Br. J. Sports Med., 40, No. 9, 773–778 (2006).
J. B. Prins, G. Bleijenberg, E. Klein Rouweler, et al., “Doctor-patient relationship in primary care of chronic fatigue syndrome: perspective of the doctor and the patient,” J. CFS, 7, 3–15 (2000).
L. Solomon, R. Nisenbaum, M. Reyes, et al., “Functional status of persons with chronic fatigue syndrome in the Wichita, Kansas, population,” Health Qualit. Life Outcomes, No. 1, 48 (2003).
A. A. Spasov, I. N. Iezhitsa, M. V. Kharitonova, and M. S. Kravchenko, “Depression-like and anxiety-related behaviour of rats fed with magnesium-deficient diet,” Zh. Vyssh. Nerv. Deyat., 58, No. 4, 476–485 (2008).
Author information
Authors and Affiliations
Additional information
Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 110, No. 11, Iss. 2 (VPPV, Suppl.), pp. 48–54, November, 2010.
Rights and permissions
About this article
Cite this article
Akarachkova, E.S. Chronic Fatigue and Approaches to Its Treatment. Neurosci Behav Physi 41, 899–905 (2011). https://doi.org/10.1007/s11055-011-9506-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11055-011-9506-6